The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York TB 500 BPC 157 GHK Cu (10 10 50 MG) Sigma Compounds FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026) BPC 157 + TB 500 Yooth Wellness Home Evexias Medical Center BPC 157 Kit Research for Tissue Repair Pathways Hydration Room